Creating a defensible plan to position your patient-specific therapy products for external investment, divestiture, or partnership/licensing involves overcoming many different challenges — as does trying to position your company as an acquisition target. Many cell therapy developers underestimate these challenges (i.e. deliverability, process automation and sustainability), which can lead to problems later on in the development process.
To help you anticipate these hardships and get a rough idea of where you are and what you will need on the path to commercial cell therapy manufacturing readiness, PCT has created the business milestone manufacturing checklist for cell therapy developers.
This checklist can help you perform a self-assessment of your manufacturing preparation so you can make improvements.
Get your personal copy of the checklist now by filling out the form on this page!